This position will play a critical role in shaping, executing, and evolving U.S. pricing and contracting strategy for a novel FcRn inhibitor that is commercially launched and expected to expand into additional indications over time.
$122,000.00 - $212,750.00; Not specified; Subject to the terms of their respective plans, employees are eligible to participate in the Company’s consolidated retirement plan (pension) and savings plan (401(k)).
Must-have
Nice-to-have
Not specified